Peripapillary Vessel Density Changes in Alzheimer's Type Dementia.
Not Applicable
Completed
- Conditions
- Alzheimer's diseaseRetinal Vessel densityOCTA
- Registration Number
- TCTR20190611003
- Lead Sponsor
- Faculty of medicine, Chulalongkorn University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Age more than 18
- Has a treatment history between 2017-2018
- TMSE score screening
- Complete ophthalmic check up history
Exclusion Criteria
- Has a previous eye disease
- Non complete history taking and psychiatrist ,ophthalmic exam.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vessel density at macular and optic disc single measurement at the beginning of the study OCTA
- Secondary Outcome Measures
Name Time Method blink rate single measurement at the beginning of the study VDO record,dry eye score single measurement at the beginning of the study OSDI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does peripapillary vessel density measured by OCTA correlate with amyloid-beta and tau pathology in Alzheimer's disease patients?
What is the comparative effectiveness of OCTA in detecting retinal vascular changes versus standard neuroimaging in early Alzheimer's diagnosis?
Which OCTA-derived retinal biomarkers predict progression of Alzheimer's disease in observational studies?
Are there management strategies for retinal vascular alterations observed in Alzheimer's type dementia using OCTA?
What existing Alzheimer's therapies target retinal vascular biomarkers identified through OCTA studies?